Volume : 08, Issue : 09, September – 2021
Title:
50.IMPACT ON PRE-EXISTING AND CHARACTERISTICS OF CORONAVIRUS DISEASE AND HEADACHE: A CROSS-SECTIONAL STUDY
Authors :
Dr Ravi Raja, Dr Kiran Kumari, Dr Sara Akram Choudhry, Dr Ayesha Akram Choudhry, Dr Komal Subhash, Dr Neeraj Parkash, Dr Sandhiya Kumari, Dr Darshan Lal
Abstract :
Introduction: The World Health Organization (WHO) identified the outbreak of the coronavirus (COVID-19) as a global pandemic in March 2020. Objectives: The main objective of the study is to analyse the impact on pre-existing and characteristics of coronavirus disease and headache. Material and methods: This cross-sectional study was conducted in Punjab Health Department during 2019 to 2020. Adult patients aged 18–65 years of both gender who were reviewed in the headache clinic within 3 months after the onset of their COVID-19. Infection with COVID-19 was confirmed by reverse transcription polymerase chain reaction (RT-PCR) technique from material collected by nasal and oropharynx swab. Results: A total of 121 patients with headache after recovery from COVID-19 were reviewed. Table 1 presents the Clinical and demographic characteristics of the cohort. Eighty-seven patients aged 40 years or younger. 89 (73.6%) reported primary headache disorders prior to COVID-19, 78 (64.5%) experienced migraine and 11 (9.1%) diagnosed as tension-type head- ache. 32 (26.4%) reported de novo headache post COVID-19. Conclusion: It is concluded that COVID-19 pandemic has a characteristic effect on the course of headaches in individuals with and without pre-existing primary headache disorders.
Cite This Article:
Please cite this article in press Ravi Raja et al, Impact On Pre-Existing And Characteristics Of Coronavirus Disease And Headache: A Cross-Sectional Study., Indo Am. J. P. Sci, 2021; 08(9).
Number of Downloads : 10
References:
1. Oran DP, Topol EJ (2020) Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med 173(5):362–367. https://doi.org/10.7326/ M20-3012
2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506. https://doi.org/1 0.1016/S0140-6736(20)30183-5
3. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 77(6):683–690. https://doi.org/10.1001/jamaneurol.2020.1127
4. Centers for Disease Control and Prevention, 2020. https://www.cdc.gov/ coronavirus/2019-ncov/symptoms-testing/symptoms.html (Accessed 17 June 2020)
5. Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38(1):1–211. https://doi.org/10.1177/0333102417738202
6. Marinis MD, Welch KM (1992) Headache associated with non-cephalic infections: classification and mechanisms. Cephalalgia 12(4):197–201. https:// doi.org/10.1046/j.1468-2982.1992.1204197.x
7. Lippi G, Mattiuzzi C, Bovo C, Henry BM (2020) Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19). Diagnosis 7(4):409–411. https://doi.org/10.1515/dx-2020-0048
8. Pinzon RT, Wijaya VO, Buana RB, Al Jody A, Nunsio PN (2020) Neurologic characteristics in coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Front Neurol 11:565. https://doi.org/10.3389/fneur.2020. 00565
9. Bolay H, Gül A, Baykan B (2020) COVID-19 is a real headache! Headache 60(7):1415–1421. https://doi.org/10.1111/head.13856
10. Carlsson AM (1983) Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 16(1):87–101. https://doi.org/1 0.1016/0304-3959(83)90088-X
11. Foster CG (1994) International ethical guidelines for biomedical research involving human subjects. J Med Ethics 20:123–124
12. World Medical Association (2013) World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 310:2191–2194
13. Hatmi ZN (2021) A systematic review of systematic reviews on the COVID- 19 pandemic. SN Compr Clin Med 26:1–8